Brain metastases: a medical neuro-oncology perspective
- PMID: 20367208
- DOI: 10.1586/ern.10.30
Brain metastases: a medical neuro-oncology perspective
Abstract
Brain metastases (BMs) are the most common neurological complication related to cancer. A review of recent and relevant literature relating to BMs was performed and found that the therapy of BMs remains controversial, notwithstanding numerous randomized clinical trials. Surgical resection of a solitary BM when possible, followed by whole-brain irradiation (WBI) is an established standard of care. More controversial is the substitution of stereotactic radiosurgery for surgery in the treatment of solitary BM. Treatment with WBI following local therapy remains controversial, with advocates for and against WBI. At present, systemic chemotherapy for BMs offers only very modest palliation. In summary, treatment of BMs remains contentious with respect to the utilization and timing of surgical resection, application of WBI and stereotactic radiosurgery, notwithstanding numerous randomized trials, as the range of interpretation of these trials has resulted in differing treatment perspectives.
Similar articles
-
[Treatment for brain metastases of lung cancer].Gan To Kagaku Ryoho. 1997 Oct;24 Suppl 3:426-31. Gan To Kagaku Ryoho. 1997. PMID: 9369918 Review. Japanese.
-
Whole brain irradiation following surgery or radiosurgery for solitary brain metastases: mature results of a prematurely closed randomized Trans-Tasman Radiation Oncology Group trial (TROG 98.05).Radiother Oncol. 2006 Sep;80(3):318-22. doi: 10.1016/j.radonc.2006.08.004. Epub 2006 Sep 7. Radiother Oncol. 2006. PMID: 16956684 Clinical Trial.
-
Single brain metastasis: resection followed by whole-brain irradiation and a boost to the metastatic site compared to whole-brain irradiation plus radiosurgery.Clin Neurol Neurosurg. 2012 May;114(4):326-30. doi: 10.1016/j.clineuro.2011.10.042. Epub 2011 Dec 5. Clin Neurol Neurosurg. 2012. PMID: 22152784
-
Combined role of whole-brain radiation therapy and radiosurgery for the treatment of brain metastasis.Prog Neurol Surg. 2012;25:228-35. doi: 10.1159/000331196. Epub 2012 Jan 6. Prog Neurol Surg. 2012. PMID: 22236684 Review.
-
Surgical treatment of solitary brain metastases.Prog Neurol Surg. 2012;25:74-81. doi: 10.1159/000331178. Epub 2012 Jan 6. Prog Neurol Surg. 2012. PMID: 22236669 Review.
Cited by
-
Treatment patterns and outcomes in BRAF V600E-mutant melanoma patients with brain metastases receiving vemurafenib in the real-world setting.Cancer Med. 2015 Aug;4(8):1205-13. doi: 10.1002/cam4.475. Epub 2015 May 20. Cancer Med. 2015. PMID: 25991583 Free PMC article.
-
Outcomes of Metastatic Brain Lesions Treated with Radioactive Cs-131 Seeds after Surgery: Experience from One Institution.Cureus. 2018 Jul 30;10(7):e3075. doi: 10.7759/cureus.3075. Cureus. 2018. PMID: 30280070 Free PMC article.
-
Phase I clinical trial outcomes in 93 patients with brain metastases: the MD anderson cancer center experience.Clin Cancer Res. 2011 Jun 15;17(12):4110-8. doi: 10.1158/1078-0432.CCR-10-3095. Epub 2011 Mar 17. Clin Cancer Res. 2011. PMID: 21415223 Free PMC article.
-
The role of cancer stem cells and miRNAs in defining the complexities of brain metastasis.J Cell Physiol. 2013 Jan;228(1):36-42. doi: 10.1002/jcp.24127. J Cell Physiol. 2013. PMID: 22689345 Free PMC article. Review.
-
Clinicopathological characteristics at primary melanoma diagnosis as risk factors for brain metastasis.Melanoma Res. 2013 Dec;23(6):461-7. doi: 10.1097/CMR.0000000000000015. Melanoma Res. 2013. PMID: 24165034 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical